Serum Perampanel Levels in Adult Epilepsy Patients With Normal Liver Function: A Case Series at Ochsner Epilepsy Center
This poster is part of a Virtual Poster Session, hosted by the Ochsner Continuing Medical Education. We encourage you to ask questions and engage in discussion on this poster! Authors will respond to comments between May 25- June 5, 2020.
Presenters
Fawad A. Khan, MD; Uma Menon, MD; Michael Pepper, MD; Uday Nadimpally, MD; Neil Billeaud, MD; Richard Eugene Ramsay, MD
It would be interesting to see the difference in serum levels at certain doses in males compared to females, as CYP3a4 is thought to be more expressed in females.
Nice poster and helpful in determining pharmacokinetics. As I understand it , there does not seem to be a consistent correlation between levels and seizure control.It would be good to also know differences in levels in children and in the elderly.
Very good presentation. Do you think the types of Epilepsy had any correlation with the response to perampanel treatment or not? I see that only one patient with Lennox-Gastaut syndrome was published. Also was there any relationship between the response to treatment in male versus female patients? Thank you!